10-98459653-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_021828.5(HPSE2):c.1700G>A(p.Arg567Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000104 in 1,613,996 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_021828.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000171 AC: 43AN: 250976Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135778
GnomAD4 exome AF: 0.000107 AC: 156AN: 1461818Hom.: 2 Cov.: 37 AF XY: 0.000120 AC XY: 87AN XY: 727194
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152178Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74338
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1700G>A (p.R567Q) alteration is located in exon 12 (coding exon 12) of the HPSE2 gene. This alteration results from a G to A substitution at nucleotide position 1700, causing the arginine (R) at amino acid position 567 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Urofacial syndrome type 1 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at